EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Impaired hematopoiesis and embryonic lethality at midgestation of mice lacking both lipid transfer proteins VPS13A and VPS13C

Peng Xu iD, Rubia Isler Mancuso, Marianna Leonzino, Caroline J Zeiss, Diane S Krause, Pietro De Camilli iD

PLOS Biology · 2025

DOI: 10.1371/journal.pbio.3003393 ↗

Kurz gefasst

Fachartikel in der Zeitschrift PLOS Biology, 2025. Verfasst von Peng Xu und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neuroscience, Yale University School of Medicine, New Haven, Connecticut, United States of America. Hauptthemen laut MEDLINE: Vesicular Transport Proteins, Hematopoiesis, Embryo Loss, Carrier Proteins. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 87 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NIDA NIH HHS, NIDDK NIH HHS, NINDS NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

VPS13 is the founding member of a family of proteins that mediate lipid transfer at intracellular membrane contact sites by a bridge-like mechanism. Mammalian genomes comprise 4 VPS13 genes encoding proteins with distinct localizations and function. The gene duplication resulting in VPS13A and VPS13C is the most recent in evolution and, accordingly, these two proteins are the most similar to each other. However, they have distinct subcellular localizations and their loss of function mutations in humans are compatible with life but result in two different age-dependent neurodegenerative diseases, chorea-acanthocytosis and Parkinson’s disease, respectively. Thus, it remains unclear whether these two proteins have overlapping functions. Here, we show that while Vps13a KO and Vps13c KO mice are viable, embryonic development of Vps13a/Vps13c double knockout (DKO) mice is arrested at midgestation. Prior to death, DKO embryos were smaller than controls, were anemic and had a smaller liver, most likely reflecting defective embryonic erythropoiesis which at this developmental stage occurs primarily in this organ. Further analyses of erythroid precursor cells showed that their differentiation was impaired and that this defect was accompanied by activation of innate immunity as revealed by upregulation of interferon stimulated genes (ISGs). Additionally, the RIG-I and MDA5 components of dsRNA triggered innate immunity were found upregulated in the DKO fetal liver. Activation of innate immunity may result from loss of integrity of the membranes of intracellular organelles, such as mitochondria and autophagic lysosomes, or to impaired autophagy, due to the absence of these lipid transport proteins. The surprising and striking synthetic effect resulting for the combined loss of VPS13A and VPS13C suggests that despite of the different localization of these two proteins, the lipid fluxes that they mediate are partially redundant.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Vesicular Transport ProteinsHematopoiesisEmbryo LossCarrier ProteinsAnimalsMice, KnockoutMiceEmbryonic DevelopmentFemaleErythropoiesisAutophagyMice, Inbred C57BLEmbryo, Mammalian

Substanzen

Vesicular Transport ProteinsVps13a protein, mouseCarrier Proteins

Autor:innen und Institutionen

  • Department of Neuroscience, Yale University School of Medicine, New Haven, Connecticut, United States of America.
  • Department of Cell Biology, Yale University School of Medicine, New Haven, Connecticut, United States of America.
  • Program in Cellular Neuroscience, Neurodegeneration and Repair, Yale University School of Medicine, New Haven, Connecticut, United States of America.
  • Aligning Science Across Parkinson's (ASAP) Collaborative Research Network, Chevy Chase, Maryland, United States of America.
  • HHMI, Yale University School of Medicine, New Haven, Connecticut, United States of America.
  • Department of Laboratory Medicine, Yale University School of Medicine, New Haven, Connecticut, United States of America.

ORCID-Profile: Peng Xu, Pietro De Camilli

Förderung

  • NIDA NIH HHS
  • NIDDK NIH HHS
  • NINDS NIH HHS
  • NIH HHS
  • Foundation for the National Institutes of Health
  • Aligning Science Across Parkinson's
  • Yale School of Medicine

Zitieren

APA

Xu, P., Mancuso, R. I., Leonzino, M., Zeiss, C. J., Krause, D. S., & De Camilli, P. (2025). Impaired hematopoiesis and embryonic lethality at midgestation of mice lacking both lipid transfer proteins VPS13A and VPS13C. PLOS Biology. https://doi.org/10.1371/journal.pbio.3003393

Vancouver

Xu P, Mancuso RI, Leonzino M, Zeiss CJ, Krause DS, De Camilli P. Impaired hematopoiesis and embryonic lethality at midgestation of mice lacking both lipid transfer proteins VPS13A and VPS13C. PLOS Biology. 2025. doi:10.1371/journal.pbio.3003393

BibTeX
@article{Xu2025,
  author = {Xu, Peng and Mancuso, Rubia Isler and Leonzino, Marianna and Zeiss, Caroline J and Krause, Diane S and De Camilli, Pietro},
  title = {Impaired hematopoiesis and embryonic lethality at midgestation of mice lacking both lipid transfer proteins VPS13A and VPS13C},
  journal = {PLOS Biology},
  year = {2025},
  doi = {10.1371/journal.pbio.3003393}
}
Kostenlos starten →